With new cases of Covid-19 having risen to more than 28,000 a day, and with soaring severe cases, restricted access to Covid-19 antiviral medicines is now a critical issue.
During the past week, academics and medical experts have called on the government to allow Covid-19 patients to gain more access to antiviral medicines, which are currently restricted to only severe cases and high-risk 608 groups comprising people aged 60 and older, those with any of seven underlying conditions and pregnant women.
